Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LOC100507520 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
OSBPL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ADAM8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VPS9D1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLXNA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYO18A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LTB4R - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TUBG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IDUA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TINCR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PIDD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OBSL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MZF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SAP25 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MINK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPTAN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HGS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VPS37C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on